Trimethobenzamide
250px | |
Systematic (IUPAC) name | |
---|---|
N-{[4-(2-dimethylaminoethoxy)phenyl]methyl}- 3,4,5-trimethoxy-benzamide | |
Clinical data | |
Routes of administration | Oral, rectal, intramuscular |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Biological half-life | 7 to 9 hours (mean) |
Identifiers | |
CAS Number | 138-56-7 |
ATC code | none |
PubChem | CID 5577 |
DrugBank | APRD01277 |
Chemical data | |
Formula | C21H28N2O5 |
Molar mass | 388.458 g/mol[[Script error: No such module "String".]] |
(verify) |
Trimethobenzamide (Tebamide, Tigan) is an antiemetic used to prevent nausea and vomiting. It is often prescribed for patients with gastroenteritis, medication-induced nausea, and other illnesses. Trimethobenzamide is generally considered the most potent antiemetic that does not have effects on the serotonergic, dopaminergic, or histaminergic systems, so it has a lower likelihood of causing undesired side effects. In the United States, it requires a prescription.
Contents
Mechanism of action
Although the specific mechanism through which trimethobenzamide functions is unknown, it is believed to affect the chemoreceptor trigger zone (CTZ) of the medulla oblongata.
Side effects
Possible side effects include drowsiness, dizziness, headache, diarrhea, muscle cramps, and blurred vision. More serious adverse effects include skin rash, tremors, parkinsonism, and jaundice.
Formulations
Trimethobenzamide is marketed under the brand names Tebamide and Tigan, manufactured by GlaxoSmithKline and King Pharmaceuticals, respectively. It is available as oral capsules and injectable formulations.
Trimethobenzamide was also available as a rectal suppository, but such formulations were banned by the U.S. Food and Drug Administration on April 6, 2007 due to unproven efficacy.[1]
See also
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
External links
- ↑ Waknine, Yael (April 6, 2007). "FDA Bans Suppositories With Trimethobenzamide". Medscape. Archived from the original on April 16, 2007. Retrieved 2007-04-06.
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugboxes which contain changes to watched fields
- All articles with dead external links
- Articles with dead external links from July 2009
- Articles with invalid date parameter in template
- Antiemetics
- Benzamides
- Phenol ethers
- 2Fix